Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation

Dana M. Kreps, Sara M. Whittle, Joanne M. Hoffman, Myron Lee Toews

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pretreatment of 1321N1 human astrocytoma cells with serum induces a pronounced increase in subsequent stimulation by forskolin and other agents of intracellular cyclic AMP accumulation, a phenomenon referred to as sensitization (Mol. Pharmacol. 39, 399-406, 1991). Pretreatment of these cells with lysophosphatidic acid induced sensitization to a similar extent as that with serum (approximately fivefold for forskolin stimulation and twofold for isoproterenol and prostaglandin E1 stimulation), with half-maximal effects at approximately 30 nM lysophosphatidic acid. Phosphatidic acid was effective but less potent whereas other lipids were ineffective. Sensitization by serum and by lysophosphatidic acid were almost completely inhibited by pertussis toxin pretreatment and partially inhibited by prolonged phorbol ester exposure to induce protein kinase C down-regulation. Among nine cell lines tested, those that exhibited sensitization with serum showed comparable sensitization with lysophosphatidic acid. The effects of both lysophosphatidic acid and serum were markedly inhibited by treatment with phospholipase B but only minimally altered with phospholipases A2, D, and C. Exposure of cells to phospholipase C alone induced approximately threefold sensitization, but both serum and lysophosphatidic acid were able to induce further three- to fourfold sensitization above that induced by phospholipase C alone. In contrast, the effects of serum and lysophosphatidic acid were not additive with each other. Together these results suggest that lysophosphatidic acid or a closely related compound present in serum is the factor responsible for sensitization of the cyclic AMP pathway.

Original languageEnglish (US)
Pages (from-to)1376-1380
Number of pages5
JournalFASEB Journal
Volume7
Issue number14
StatePublished - Jan 1 1993

Fingerprint

Cyclic AMP
Serum
Type C Phospholipases
Colforsin
Cells
Lysophospholipase
Phospholipase D
Phosphatidic Acids
lysophosphatidic acid
Alprostadil
Phospholipases A2
Pertussis Toxin
Astrocytoma
Phorbol Esters
Isoproterenol
Protein Kinase C
Down-Regulation
Lipids
Cell Line

Keywords

  • glial cells
  • mitogenesis
  • pertussis toxin
  • phosphatidic acid
  • phospholipase C

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Kreps, D. M., Whittle, S. M., Hoffman, J. M., & Toews, M. L. (1993). Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. FASEB Journal, 7(14), 1376-1380.

Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. / Kreps, Dana M.; Whittle, Sara M.; Hoffman, Joanne M.; Toews, Myron Lee.

In: FASEB Journal, Vol. 7, No. 14, 01.01.1993, p. 1376-1380.

Research output: Contribution to journalArticle

Kreps, DM, Whittle, SM, Hoffman, JM & Toews, ML 1993, 'Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation', FASEB Journal, vol. 7, no. 14, pp. 1376-1380.
Kreps, Dana M. ; Whittle, Sara M. ; Hoffman, Joanne M. ; Toews, Myron Lee. / Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. In: FASEB Journal. 1993 ; Vol. 7, No. 14. pp. 1376-1380.
@article{d0b9333e4a3d45648f700697c08d0e83,
title = "Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation",
abstract = "Pretreatment of 1321N1 human astrocytoma cells with serum induces a pronounced increase in subsequent stimulation by forskolin and other agents of intracellular cyclic AMP accumulation, a phenomenon referred to as sensitization (Mol. Pharmacol. 39, 399-406, 1991). Pretreatment of these cells with lysophosphatidic acid induced sensitization to a similar extent as that with serum (approximately fivefold for forskolin stimulation and twofold for isoproterenol and prostaglandin E1 stimulation), with half-maximal effects at approximately 30 nM lysophosphatidic acid. Phosphatidic acid was effective but less potent whereas other lipids were ineffective. Sensitization by serum and by lysophosphatidic acid were almost completely inhibited by pertussis toxin pretreatment and partially inhibited by prolonged phorbol ester exposure to induce protein kinase C down-regulation. Among nine cell lines tested, those that exhibited sensitization with serum showed comparable sensitization with lysophosphatidic acid. The effects of both lysophosphatidic acid and serum were markedly inhibited by treatment with phospholipase B but only minimally altered with phospholipases A2, D, and C. Exposure of cells to phospholipase C alone induced approximately threefold sensitization, but both serum and lysophosphatidic acid were able to induce further three- to fourfold sensitization above that induced by phospholipase C alone. In contrast, the effects of serum and lysophosphatidic acid were not additive with each other. Together these results suggest that lysophosphatidic acid or a closely related compound present in serum is the factor responsible for sensitization of the cyclic AMP pathway.",
keywords = "glial cells, mitogenesis, pertussis toxin, phosphatidic acid, phospholipase C",
author = "Kreps, {Dana M.} and Whittle, {Sara M.} and Hoffman, {Joanne M.} and Toews, {Myron Lee}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "1376--1380",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "14",

}

TY - JOUR

T1 - Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation

AU - Kreps, Dana M.

AU - Whittle, Sara M.

AU - Hoffman, Joanne M.

AU - Toews, Myron Lee

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Pretreatment of 1321N1 human astrocytoma cells with serum induces a pronounced increase in subsequent stimulation by forskolin and other agents of intracellular cyclic AMP accumulation, a phenomenon referred to as sensitization (Mol. Pharmacol. 39, 399-406, 1991). Pretreatment of these cells with lysophosphatidic acid induced sensitization to a similar extent as that with serum (approximately fivefold for forskolin stimulation and twofold for isoproterenol and prostaglandin E1 stimulation), with half-maximal effects at approximately 30 nM lysophosphatidic acid. Phosphatidic acid was effective but less potent whereas other lipids were ineffective. Sensitization by serum and by lysophosphatidic acid were almost completely inhibited by pertussis toxin pretreatment and partially inhibited by prolonged phorbol ester exposure to induce protein kinase C down-regulation. Among nine cell lines tested, those that exhibited sensitization with serum showed comparable sensitization with lysophosphatidic acid. The effects of both lysophosphatidic acid and serum were markedly inhibited by treatment with phospholipase B but only minimally altered with phospholipases A2, D, and C. Exposure of cells to phospholipase C alone induced approximately threefold sensitization, but both serum and lysophosphatidic acid were able to induce further three- to fourfold sensitization above that induced by phospholipase C alone. In contrast, the effects of serum and lysophosphatidic acid were not additive with each other. Together these results suggest that lysophosphatidic acid or a closely related compound present in serum is the factor responsible for sensitization of the cyclic AMP pathway.

AB - Pretreatment of 1321N1 human astrocytoma cells with serum induces a pronounced increase in subsequent stimulation by forskolin and other agents of intracellular cyclic AMP accumulation, a phenomenon referred to as sensitization (Mol. Pharmacol. 39, 399-406, 1991). Pretreatment of these cells with lysophosphatidic acid induced sensitization to a similar extent as that with serum (approximately fivefold for forskolin stimulation and twofold for isoproterenol and prostaglandin E1 stimulation), with half-maximal effects at approximately 30 nM lysophosphatidic acid. Phosphatidic acid was effective but less potent whereas other lipids were ineffective. Sensitization by serum and by lysophosphatidic acid were almost completely inhibited by pertussis toxin pretreatment and partially inhibited by prolonged phorbol ester exposure to induce protein kinase C down-regulation. Among nine cell lines tested, those that exhibited sensitization with serum showed comparable sensitization with lysophosphatidic acid. The effects of both lysophosphatidic acid and serum were markedly inhibited by treatment with phospholipase B but only minimally altered with phospholipases A2, D, and C. Exposure of cells to phospholipase C alone induced approximately threefold sensitization, but both serum and lysophosphatidic acid were able to induce further three- to fourfold sensitization above that induced by phospholipase C alone. In contrast, the effects of serum and lysophosphatidic acid were not additive with each other. Together these results suggest that lysophosphatidic acid or a closely related compound present in serum is the factor responsible for sensitization of the cyclic AMP pathway.

KW - glial cells

KW - mitogenesis

KW - pertussis toxin

KW - phosphatidic acid

KW - phospholipase C

UR - http://www.scopus.com/inward/record.url?scp=0027363845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027363845&partnerID=8YFLogxK

M3 - Article

C2 - 8224610

AN - SCOPUS:0027363845

VL - 7

SP - 1376

EP - 1380

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 14

ER -